We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Bion Plc | LSE:BION | London | Ordinary Share | JE00BYTQ7945 | ORD NPV |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.15 | 0.00 | 00:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Nov 2022 to Nov 2024
TIDMBION
RNS Number : 3268O
Bion PLC
31 January 2023
31 January 2023
BiON plc
("BiON" or the "Company")
Interim Results
BiON (AIM: BION), an AIM Rule 15 cash shell, announces its unaudited interim results for the six months ended 31 October 2022.
Due to the Company changing its financial year end, as announced on 5 October 2022, the comparative period represents the six months from 1 January 2021 to 30 June 2021 ("H1 2021").
Summary
-- During the period, the Company operated as an AIM Rule 15 cash shell
-- The Company actively sought a suitable reverse candidate and assessed various business opportunities
-- As a result of not completing a reverse takeover by 20 October 2022 (being six months from the date the Company became an AIM Rule 15 cash shell), trading on AIM in the Company's ordinary shares was suspended on 20 October 2022
-- From the suspension date, BiON has six months to complete an acquisition, or acquisitions, which constitutes a reverse takeover under AIM Rule 14 otherwise admission to trading on AIM will be cancelled
-- As at 31 October 2022, BiON had cash and cash equivalents of GBP480 thousand (30 April 2022: GBP1 thousand; 30 June 2021: GBP179 thousand)*
* Following becoming an AIM Rule 15 cash shell, the Company has, from 1 May 2022, adopted Pound Sterling (GBP) as its functional presentational currency. Accordingly, the results for the previous periods have been restated in GBP based on the prevailing foreign exchange rate as at the balance sheet date (30 April 2022 and 30 June 2021) and average rate for the six-month period for the H1 2021 income statement ( 1 January 2021 to 30 June 2021). See the Financial Review for further details.
This announcement contains inside information for the purposes of Article 7 of Regulation 2014/596/EU which is part of domestic UK law pursuant to the Market Abuse (Amendment) (EU Exit) regulations (SI 2019/310).
Enquiries:
Hot Features
Premium
BiON plc
+44 20 4582
c/o Gracechurch Group 3500
Beaumont Cornish Limited (Nominated Adviser)
+44 20 7628
Roland Cornish, Asia Szusciak 3396
Optiva Securities Limited (Broker)
+44 20 3137
Vishal Balasingham 1903
Gracechurch Group (Financial PR Adviser)
+44 20 4582
Claire Norbury 3500
Strategic Report
Overview
The Company is an AIM Rule 15 cash shell whose principal activity is to identify potential acquisition opportunities. The Company's strategy is to acquire a business that is seeking an AIM quoted platform via a reverse takeover. The Directors will consider opportunities in a number of sectors and will focus on an acquisition that can create value for shareholders in the form of capital growth and/or dividends.
During the period under review, the Company actively sought a suitable reverse candidate and assessed various business opportunities. As a result of not completing a reverse takeover by 20 October 2022 (being six months from the date the Company became an AIM Rule 15 cash shell), trading on AIM in the Company's ordinary shares was suspended on 20 October 2022.
Outlook
Since period end, the Company has been active in its search for acquisition opportunities and is reviewing a number of potential candidates. BiON has six months from 20 October 2022 to complete an acquisition, or acquisitions, which constitutes a reverse takeover under AIM Rule 14 otherwise admission to trading on AIM will be cancelled.
The Company will update the market as appropriate.
Financial Review
This report covers the six months ended 31 October 2022. As noted, due to the Company changing its financial year end, the comparative period represents the six months from 1 January 2021 to 30 June 2021.
Change in functional and presentational currency
Prior to becoming an AIM Rule 15 cash shell, the Company's operating entity, BiON Ventures Sdn Bhd ("BVSB"), transacted primarily in Malaysian Ringgit (MYR) and, accordingly, its functional and presentational currency was MYR. Following the disposal of BVSB and becoming an AIM Rule 15 cash shell, the Company incurs costs in Pound Sterling (GBP), which are of an administrative and professional fee nature. As a result, the Company adopted, from 1 May 2022, GBP as its functional and presentational currency. The results for the prior periods have been restated in GBP based on the prevailing foreign exchange rate as at the balance sheet date (30 April 2022 and 30 June 2021) and average rate for the six-month period for the H1 2021 income statement ( 1 January 2021 to 30 June 2021).
Results summary
GBP000's Six months to 31 October Six months to 30
2022 June 2021
(Unaudited) (Unaudited)
Revenue - 98
-------------------------- ------------------
Operating expenses (99) (898)
-------------------------- ------------------
Loss before tax (99) (1,671)
-------------------------- ------------------
Loss per share (0.00023) (0.0039)
-------------------------- ------------------
The results reflect the six months to 31 October 2022 being a period when the Company was a cash shell, having disposed of its operating entity on 19 April 2022. As noted above, the operating expenses incurred during the period consist primarily of administrative and professional fees.
Cash flow and funds
Net cash used in operating activities was GBP479 thousand (H1 2021: GBP796 thousand). Cash and cash equivalents at 31 October 2022 was GBP480 thousand (30 April 2022: GBP1 thousand; 30 June 2021: GBP179 thousand).
CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION
31.10.2022 30.06.2021 30.04.2022
GBP'000 GBP'000 GBP'000
unaudited unaudited audited
ASSETS
NON-CURRENT ASSETS
Intangible assets - 121 -
Property, plant and equipment - 15,969 -
Right-of-use assets - 827 -
Total non-current assets - 16,917 -
--------------- ----------- -----------
CURRENT ASSETS
Trade and other receivables 19 1,937 1,001
Amounts due from related - 526 -
parties
Cash and cash equivalents 480 179 1
Total current assets 499 2,642 1,002
--------------- ----------- -----------
Total assets 499 19,559 1,002
=============== =========== ===========
EQUITY
Stated capital 13,701 12,073 13,701
Foreign translation reserve (42) (463) (42)
Retained loss (13,469) (23,306) (13,370)
Merger reserve - (700) -
Total shareholders' equity 190 (12,396) 289
Non-controlling interests - 25 -
Total equity 190 (12,371) 289
--------------- ----------- -----------
CURRENT LIABILITIES
Trade and other payables 126 19,964 570
Lease liabilities - 84 -
Short-term borrowings 35 450 -
Income tax liabilities - 248 -
Total current liabilities 161 20,746 570
--------------- ----------- -----------
NON-CURRENT LIABILITY
Government grants deferred - 13 -
income
Long-term borrowings - 9,854 -
Lease liabilities - 978 -
Amounts due to directors 148 325 143
Deferred taxation - 14 -
Total non-current liabilities 148 11,184 143
--------------- ----------- -----------
Total liabilities 309 31,930 713
--------------- ----------- -----------
Total liabilities and equity 499 19,559 1,002
=============== =========== ===========
CONDENSED CONSOLIDATED STATEMENT OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME
PERIOD ENDED PERIOD
ENDED
31.10.2022 30.06.2021
GBP'000 GBP'000
unaudited unaudited
Revenue - 98
Cost of sales - (738)
Gross (loss)/profit - (640)
Other income 36
Less: operating expenses
Administrative expenses (99) (898)
Operating loss (99) (1,502)
Finance income - 228
Finance costs - (397)
Loss before taxation (99) (1,671)
Income tax expense - -
Loss for the year (99) (1,671)
--------------- -----------
Other comprehensive loss
Exchange difference on translation of foreign
operations - (14)
Total comprehensive loss (99) (1,685)
=============== ===========
Loss per share:
Basic (RM) (0.00023) (0.0039)
Diluted (RM) (0.00023) (0.0039)
=============== ===========
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
PERIOD ENDED PERIOD
ENDED
31.10.2022 30.06.2021
GBP'000 GBP'000
unaudited unaudited
CASH FLOW FROM OPERATING ACTIVITIES
Loss before taxation (99) (1,671)
Adjustments for:
Amortisation of intangible assets - 5
Depreciation of property, plant and equipment - 351
Depreciation of right-of-use assets - 54
Government grant income - (1)
Interest expenses: -
- Lease liabilities interest - 56
- Loan interest - 341
Interest income - (228)
Unrealised gain on foreign exchange - (35)
Cash flow used in operating activities before
working capital changes (99) (1,128)
Decrease in trade and other receivables 982 1,401
(Decrease)/increase in trade and other payables (404) 1,169
(Increase)/decrease in amount due from related
parties - (303)
--------------- -----------
Cash flow from operating activities 479 1,139
Interest paid - (343)
Interest received - -
--------------- -----------
NET CASH FLOW FROM OPERATING ACTIVITIES 479 796
--------------- -----------
CASH FLOW FOR INVESTING ACTIVITIES
Purchase of property, plant and equipment - (912)
NET CASH FLOW FROM/(USED IN) INVESTING ACTIVITIES 479 (912)
--------------- -----------
CASH FLOW FOR FINANCING ACTIVITIES
Principle elements of lease payment - (93)
NET CASH FLOW FROM/(USED IN) FINANCING ACTIVITIES - (93)
--------------- -----------
Net increase/(decrease) in cash and cash
equivalents 479 (209)
Effects of foreign exchange translation - (19)
Cash and cash equivalents at the beginning
of the period 1 407
--------------- -----------
Cash and cash equivalents at the end of
the period 480 179
--------------- -----------
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
1. BASIS OF PREPARATION
The interim report has been prepared in accordance with UK adopted International Accounting Standards, including related interpretations issued by the International Financial Reporting Interpretations Committee ("IFRIC").
As permitted by Companies (Jersey) Law 1991 only the consolidated financial statements are presented.
The financial statements are presented in GBP unless otherwise stated and is the currency of the primary economic environment in which the Company now operates. All values are rounded to the nearest thousand pounds ("GBP'000") except where otherwise indicated.
Change in functional and presentational currency
Prior to becoming an AIM Rule 15 cash shell, the Company's operating entity, BiON Ventures Sdn Bhd ("BVSB"), transacted primarily in Malaysian Ringgit (MYR) and, accordingly, its functional and presentational currency was MYR. Following the disposal of BVSB and becoming an AIM Rule 15 cash shell, the Company incurs costs in Pound Sterling (GBP), which are of an administrative and professional fee nature. As a result, the Company adopted, from 1 May 2022, GBP as its functional and presentational currency. The results for the prior periods have been restated in GBP based on the prevailing foreign exchange rate as at the balance sheet date (30 April 2022 and 30 June 2021) and average rate for the six-month period for the H1 2021 income statement (1 January 2021 to 30 June 2021).
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
IR SDAESSEDSELF
(END) Dow Jones Newswires
January 31, 2023 02:00 ET (07:00 GMT)
1 Year Bion Chart |
1 Month Bion Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
